{"id":118362,"date":"2014-03-22T08:48:51","date_gmt":"2014-03-22T12:48:51","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/dartmouth-cancer-researcher-on-genetic-based-testing-and-treatment-for-breast-cancer.php"},"modified":"2014-03-22T08:48:51","modified_gmt":"2014-03-22T12:48:51","slug":"dartmouth-cancer-researcher-on-genetic-based-testing-and-treatment-for-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/dartmouth-cancer-researcher-on-genetic-based-testing-and-treatment-for-breast-cancer.php","title":{"rendered":"Dartmouth Cancer Researcher on Genetic-Based Testing and Treatment for Breast Cancer"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Dr. Tsongalis is the director of the Molecular Pathology    laboratory and co-director of the translational research    program in the Geisel School of Medicine at Dartmouth, the    Dartmouth Hitchcock Medical Center, and the Norris Cotton    Cancer Center in Lebanon, N.H. In 1994, he completed his    post-doctoral training in clinical chemistry at the University    of North Carolina, Chapel Hill, where he was first exposed to    molecular diagnostics. Throughout his career, Dr. Tsongalis has    been striving to apply molecular techniques to diagnostic    questions that are not adequately addressed by traditional    laboratory methods and has challenged the boundaries between    clinical pathology and anatomic pathology. His early work    described methods for localized in situ amplification of DNA    and RNA targets in tissue sections as well as the    identification of mutation carriers in the BRCA1 and BRCA2    breast cancer risk genes. He described some of the first    applications of molecular methods in identity testing of    clinical specimens when mislabeling or a mix-up was suspected.    His laboratory was an early adopter of automation for    high-volume molecular infectious disease testing and active in    the development of molecular techniques for use with    unconventional specimen types. His laboratory is currently    applying state-of-the-art molecular techniques to improve    patient management through precision medicine. His laboratory    continually pushes the application of molecular technologies    beyond their traditional uses and is now focusing on    nanotechnologies for routine use in the clinical setting. His    work has led to 140 publications and eight textbooks in the    field of molecular pathology. Dr. Tsongalis has served on many    professional society committees, including the AACC board of    directors, and the editorial boards of several medical    journals, including Clinical Chemistry.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more from the original source: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/615463\/?sc=rsmn\/RS=^ADAoDHhE0EB5HxUOa69VowyWgWkY.g-\" title=\"Dartmouth Cancer Researcher on Genetic-Based Testing and Treatment for Breast Cancer\">Dartmouth Cancer Researcher on Genetic-Based Testing and Treatment for Breast Cancer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Dr. Tsongalis is the director of the Molecular Pathology laboratory and co-director of the translational research program in the Geisel School of Medicine at Dartmouth, the Dartmouth Hitchcock Medical Center, and the Norris Cotton Cancer Center in Lebanon, N.H. In 1994, he completed his post-doctoral training in clinical chemistry at the University of North Carolina, Chapel Hill, where he was first exposed to molecular diagnostics.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/dartmouth-cancer-researcher-on-genetic-based-testing-and-treatment-for-breast-cancer.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-118362","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/118362"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=118362"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/118362\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=118362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=118362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=118362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}